United States · Bill · S
S. 3049 (116th)
LAB Act
Introduced
12 December 2019
Last action
12 December 2019 · Introduced
Status
Read twice and referred to the Committee on Finance.
Sponsors
Sen. Brown, Sherrod [D-OH], Sen. Burr, Richard [R-NC], Sen. Menendez, Robert [D-NJ], Rep. Roberts, Pat [R-KS-1], Michael Bennet, Thomas Tillis
Subjects
Healthcare
Source updated
7 April 2025
Summary
Laboratory Access for Beneficiaries Act or the LAB Act This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services for purposes of determining Medicare payment rates. Additionally, the Medicare Payment Advisory Commission must evaluate the methodology used to determine a specified laboratory fee schedule.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
12 December 2019
Introduced
Introduced in Senate
Source: IntroReferral
12 December 2019
Introduced
Read twice and referred to the Committee on Finance.
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 12 December 2019 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 12 December 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 12 December 2019
Introduced in Senate
summary · EN · 12 December 2019
Sponsors
- Sen. Brown, Sherrod [D-OH] · D · Sponsor
- Sen. Burr, Richard [R-NC] · R · Sponsor
- Sen. Menendez, Robert [D-NJ] · D · Cosponsor
- Rep. Roberts, Pat [R-KS-1] · R · Cosponsor
- Michael Bennet · D · Cosponsor
- Thomas Tillis · R · Cosponsor
- · ssfi00 · Standing
Related records
- related to → Further Consolidated Appropriations Act, 2020
- related to → LAB Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/3049
- Open data entity: https://api.congress.gov/v3/bill/116/s/3049
- us · 116-s-3049 · source updated 7 April 2025